# OnCo record sil204 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/sil204/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "sil204" ;
  schema:name "SIL204"@en ;
  schema:description "SIL204 is a gene-silencing medicine from Silexion Therapeutics that stops cancer cells making the KRAS protein that drives them. It is given with chemotherapy and is in a larger trial in pancreatic cancer."@en ;
  schema:url <https://onco.cc/drugs/sil204/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/2022416/000117891326004003/zk2635896.htm> ;
  onco:status "phase-2" ;
  onco:tag "pipeline" ;
  onco:modality "siRNA (intratumoral and subcutaneous)" ;
  onco:technologies <https://onco.cc/technologies/antisense-sirna/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:companies <https://onco.cc/companies/silexion-therapeutics/> .